Spain
· Delayed Price · Currency is EUR HBX Group International Statistics
Total Valuation
BME:HBX has a market cap or net worth of EUR 1.95 billion. The enterprise value is 4.61 billion.
| Market Cap | 1.95B |
| Enterprise Value | 4.61B |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:HBX has 247.24 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 247.24M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 9.52% |
| Float | 217.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.64 |
| PS Ratio | 2.81 |
| PB Ratio | -1.39 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.35 |
| P/OCF Ratio | 4.34 |
| PEG Ratio | 0.47 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.88, with an EV/FCF ratio of 10.29.
| EV / Earnings | -192.03 |
| EV / Sales | 6.65 |
| EV / EBITDA | 11.88 |
| EV / EBIT | 16.17 |
| EV / FCF | 10.29 |
Financial Position
The company has a current ratio of 0.88
| Current Ratio | 0.88 |
| Quick Ratio | 0.84 |
| Debt / Equity | n/a |
| Debt / EBITDA | 8.62 |
| Debt / FCF | 7.46 |
| Interest Coverage | 0.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 5.17% |
| Return on Invested Capital (ROIC) | 8.91% |
| Return on Capital Employed (ROCE) | 14.63% |
| Revenue Per Employee | 192,500 |
| Profits Per Employee | -6,667 |
| Employee Count | 3,600 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 36.48 |
| Average Volume (20 Days) | 205,652 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:HBX had revenue of EUR 693.00 million and -24.00 million in losses. Loss per share was -0.20.
| Revenue | 693.00M |
| Gross Profit | 635.00M |
| Operating Income | 285.00M |
| Pretax Income | -48.00M |
| Net Income | -24.00M |
| EBITDA | 388.00M |
| EBIT | 285.00M |
| Loss Per Share | -0.20 |
Balance Sheet
The company has 686.00 million in cash and 3.34 billion in debt, giving a net cash position of -2.66 billion or -10.75 per share.
| Cash & Cash Equivalents | 686.00M |
| Total Debt | 3.34B |
| Net Cash | -2.66B |
| Net Cash Per Share | -10.75 |
| Equity (Book Value) | -1.40B |
| Book Value Per Share | -11.48 |
| Working Capital | -177.00M |
Cash Flow
In the last 12 months, operating cash flow was 449.00 million and capital expenditures -1.00 million, giving a free cash flow of 448.00 million.
| Operating Cash Flow | 449.00M |
| Capital Expenditures | -1.00M |
| Free Cash Flow | 448.00M |
| FCF Per Share | 1.81 |
Margins
Gross margin is 91.63%, with operating and profit margins of 41.13% and -3.46%.
| Gross Margin | 91.63% |
| Operating Margin | 41.13% |
| Pretax Margin | -6.93% |
| Profit Margin | -3.46% |
| EBITDA Margin | 55.99% |
| EBIT Margin | 41.13% |
| FCF Margin | 64.65% |
Dividends & Yields
BME:HBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.23% |
| FCF Yield | 22.97% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:HBX has an Altman Z-Score of -0.21. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.21 |
| Piotroski F-Score | n/a |